Table 1.
Cell line | MTT | BrdU-ELISA | LDH | |||
---|---|---|---|---|---|---|
CBD | CBDV | CBD | CBDV | CBD | CBDV | |
A549 | 27.66 (23.82–32.12) | 32.91 (27.89–38.83) | 40.38 (29.08–56.05) | 48.63 (33.94–69.67) | 23.96 (18.47–31.09) | 26.30 (24.11–28.69) |
Caco-2 | 35.24 (28.23–43.98) | 46.02 (40.01–52.93) | 33.32 (25.41–43.69) | 40.39 (29.78–54.85) | 22.75 (16.12–32.12) | 29.09 (23.55–35.94) |
Hep G2 | 15.80 (11.33–22.04) | 19.74 (13.86–28.10) | 39.21 (31.60–48.64) | 46.68 (39.81–54.75) | 18.14 (14.72–22.36) | 21.16 (17.49–25.60) |
MDA-MB-231 | 25.84 (23.61–28.28) | 38.09 (32.39–44.83) | 38.38 (34.50–42.68) | 46.82 (37.29–58.83) | 22.13 (18.25–26. 82) | 33.77 (26.37–43.25) |
TelCOFS02MA | 31.89 (25.05–40.61) | 42.30 (26.93–66.44) | 49.14 (32.71–73.83) | 69.14 (55.39–86.31) | 118.00 (39.10–356.10) | 151.70 (58.10–396.20) |
MTT assay, BrdU-ELISA and LDH assay IC50 values, expressed in µM, with confidence intervals of 95% for the cell lines after 72 h of exposure to CBD and CBDV.